Anglo French Drug & Industries ltd.: About the company
Anglo-French Drugs & Industries Limited (AFDIL) is a pharmaceutical company known for importing and selling pharmaceutical products. Established in 1942, AFDIL’s flagship product, “BEPLEX” B-Complex tablets, has been a key offering. The company was acquired by the Kanoria Group in 1985, with Mr. Abhay Kanoria taking over management in 1989. In 1994, AFDIL diversified into manufacturing furnishing fabrics. The company’s WHO-GMP-approved facility in Peenya, Bangalore, has a triple-shift capacity to produce 1,500 million tablets annually, along with other dosage forms like oral liquids and injectables.
- First in India to produce single vitamin injections and B-complex vitamin combinations.
- Committed to quality, adhering to cGMP standards and validated technology for affordable pharmaceutical products.
- WHO GMP certified for its dedication to quality and safety.
- Recognized by the Ministry of Science and Technology for its innovative R&D in tablets, capsules, and liquid orals.
- Offers over 300 products across nutraceuticals, CNS, skin, and respiratory segments.
- Operates divisions like AFD Pharma, Hospicare, Optima, Trading, and Export for advanced pharmaceutical solutions.
- Celebrating 100 years of excellence and innovation in the pharmaceutical industry.
| Name | Anglo-French Drugs & Industries Ltd (Buy Unlisted shares) |
| Registration Date | 1/2/1923 |
| Category | Indian Non- Government Company |
| Industry | Pharma |
| Listing Status | Listed |
| Registered Address | Peenya,Bengaluru, Karnataka,560058 |
Business segments
AFD Pharma
- Focuses Specializes in products for an aging population, emphasizing wellness and immunity.
- Offers a comprehensive portfolio, including immunity boosters, fertility support, liver health supplements, women’s health products, and general well-being.
Hospicare:
- Focuses on products for orthopedic doctors and general health.
- Leverages established channels in the institutional and surgical markets.
- Aims to synergistically grow as a preferred partner for doctors.
- Known for being a top pharmaceutical, drugs, and medicine manufacturing company in India.
- Committed to providing high-quality pharmaceutical products at affordable prices.
- Some of their products are Afdical Advance Tablets, Anglogesic Plus Gel, Cartitone Tablets etc
Export:
- Established in 1997, beginning with product registrations in Russia.
- Expanded presence to 16 countries across Eastern Europe, Southeast Asia, and Africa.
- Shifted from a trading-focused approach to a marketing strategy in multiple countries.
- Active marketing presence in Belarus, Mauritius, and Myanmar with dedicated field forces.
- Offers a wide range of APIs (Active Pharmaceutical Ingredients), including vitamins, antibiotics, and other pharmaceutical compounds.
- Recognized for meeting and exceeding international customer expectations in pharmaceutical exports
Optima:
- Partners with M/s. Recova Pharma Expo Pvt. Ltd. to distribute AFDIL’s medicines widely across India
- Offers over 350 products across various therapeutic segments.
- Ensures medicines are available at affordable prices to all.
- Specializes in manufacturing generic medicines in India.
Trading:
- Specializes in supplying raw materials, particularly vitamins and APIs, to pharmaceutical manufacturers.
- Strong expertise in sourcing high-quality vitamins and APIs both from India and overseas.
- Partners with top institutions and manufacturers in India to provide premium quality pharmaceutical ingredients.
- Acts as a comprehensive formulator, supplier, and distributor of high-quality pharmaceutical ingredients in vitamins and all pharmaceutical APIs.
- Offers a wide range of APIs, including vitamins (such as Vitamin C, B5, B6, B12), antibiotics (Azithromycin, Cefixime, Ceftriaxone), and other compounds (like Metronidazole, Diclofenac Sodium, Pantaprazole Pellets).
Product Portfolio
AFD Pharma
- AFD Shield:
- A comprehensive multivitamin supplement for adults and the elderly.
- Livocumin:
- Ayurvedic liver medicine that cleanses, detoxifies, and strengthens the liver.
- Neugracia:
- Menopause supplement designed for relief from menopausal symptoms.
- Contains natural extracts with multivitamins and minerals.
- Limezo DZ:
- Immunity booster supplement with Vitamin C, Vitamin D3, and Zinc.
- Fastnap Melatonin Oral Spray:
- Natural sleep aid designed to improve sleep quality
Hospicare
- AFDICAL ADVANCE Tablets:
- Supports stronger bones.
- Reduces joint pain and inflammation.
- ANGLOGESIC PLUS Gel:
- Provides faster relief from sprains, swelling, inflammation, and pain.
- CARTITONE Tablets:
- Eases physical movements.
- Provides relief from joint pain.
- L-STYLE Tablets:
- Helps reduce fatigue and weakness.
- Lowers oxidative stress and supports brain function.
- KAL-D3 Tablets:
- Strengthens weak and brittle bones.
- Boosts immunity
AFD Export
- Tedyvit Vitamin B Complex Gummies:
- Contains all B vitamins, along with choline and inositol.
- Tedyvit Multivitamin & Minerals Gummies:
- Suitable for children, teenagers, and adults.
- Freshitol Hand Sanitizer:
- Kills 99.9% of germs.
- Hydrates the skin.
- Easy to use with leak-lock protection. Available in a 72% alcohol-based formula
Management
Mr. Abhay Kanoria Chairman & Managing Director
Mr. Abhay Kanoria, Chairman and Managing Director of AFDIL, brings extensive experience in the pharmaceutical industry and is committed to driving innovation and growth within the company. Under his leadership, AFDIL has expanded its reach both in Indian and global markets, focusing on delivering high-quality, affordable pharmaceutical products. Known for his strategic vision and dedication to excellence, Mr. Kanoria ensures that AFDIL remains at the forefront of technological advancements in the pharmaceutical sector through a strong emphasis on research and development.
..
Mr. Uddhav Kanoria President & Whole-time Director
Mr. Uddhav Kanoria, President and Whole-time Director of AFDIL, has 18 years of experience in the pharmaceutical industry. He focuses on strategic growth, innovation, and expanding AFDIL’s market presence. With a BBA from The University of Texas, he plays a key role in advancing research and development to enhance product quality and affordability, earning a reputation for excellence and continuous improvement
…
Mr. Nirbhay Kanoria President & Director
Mr. Nirbhay Kanoria, President and Director of AFDIL, focuses on strategic growth and innovation within the company, aiming to provide affordable, high-quality healthcare products. He actively supports the advancement of AFDIL’s research and development efforts, helping to maintain the company’s competitiveness in both domestic and international markets.
Shareholding pattern
| Name | Shareholding % |
| Abhay Kanoria | 54.5% |
| Ninaad Finance Properties private ltd. | 10.4% |
Industry overview
India is a major global player in the pharmaceutical industry, known for its affordable manufacturing and skilled workforce. As the largest producer of generic medicines, it meets a substantial portion of global vaccine and generic drug needs, especially in markets like the US and UK. The industry’s growth, similar to Anglo-French Drugs & Industries Limited (AFDIL), has been driven by local expertise, cost reduction, and global expansion. While challenges like limited R&D investment and regulatory pressures exist, there are significant growth opportunities in exports, generic drug production, and R&D.
Anglo-French Drugs & Industries Donates State-of-the-Art Vestibulator to Support Children with Neurological Disorders (July 2022)
Anglo-French Drugs & Industries Ltd (AFDIL), a leading Indian pharmaceutical company with a 99-year history, recently donated a state-of-the-art Vestibulator to SRCC Children’s Hospital in Mumbai. This custom-made machine, designed by IIT and the second of its kind in the city, will assist in the recovery of children with neurological issues such as autism and cerebral palsy, particularly those from lower economic backgrounds. AFDIL’s Chairman, Abhay Kanoria, highlighted the company’s dedication to improving healthcare, especially in neglected areas like the vestibular system. Renowned for its brands in nutraceuticals, CNS, skin, and respiratory care, AFDIL serves over 65,000 doctors and 50,000 chemists globally, focusing on delivering high-quality medications and services.
Anglo-French Drugs Launches AFD-NP for Effective Treatment of Neuropathic Pain (Feb 2023)
Anglo-French Drugs & Industries Ltd. has launched AFD-NP, a new medication for treating moderate to severe neuropathic pain. AFD-NP, approved by the Drug Control Department, combines 10 mg of Nortriptyline and 75 mg of Pregabalin, a formulation recommended by experts for its effectiveness in managing neuropathy, particularly in the Indian context. The company’s Chairman and Managing Director, Mr. Abhay Kanoria, highlighted the growing need for such treatments due to the increasing prevalence of diabetes-related neuropathic pain and expressed confidence in the product’s success due to its quality and advanced technology. AFD-NP is priced at Rs.160 per strip of 10 tablets and is positioned as superior to alternatives containing Nortriptyline and Gabapentin.
Financial Highlights
₹ in crores
| Particulars | FY 2023-24 | FY 2022-23 | decrease % |
| Revenue from Operations | 100 | 110 | -9.3 |
| EBTDA | -7.29 | 256 | _ |
| Profit after Tax | -12.34 | 191 | _ |
| EPS | -99 | 1478 |
In FY 2023, the company benefited from an exceptional profit of ₹29,127 lakhs from the sale of trademarks, resulting in a total profit of ₹191 crore.
Revenue from operations breakdown
| REVENUE FROM OPERATION | March 31st, 2024 | March 31st, 2023 |
| a) Sale of products | ||
| Pharmaceutical | 9,496 | 10,232 |
| b) Other operating revenues | ||
| Sale of scrap | 6 | 5 |
| Conversion charges/income from job work | 10 | 10 |
| Commission received | 1 | 4 |
| Miscellaneous income – Operating Income | 7 | _ |
| Total Revenue from Operations | 9,520 | 10,251 |
Valuation
| Valuation | 31st March, 2023 |
| Share Price | 3299 |
| Outstanding shares | 1,233,382 |
| MCAP | 407 Cr. (Approx) |
| P/S Ratio | 4.08 |
| P/B Ratio | 2.38 |
| Book value per share | 1384 |
Peer Comparison
| Particulars | Anglo French Drug &Industries LTD. | Pfizer Ltd (standalone) | Sanofi India | Procter & Gamble Health Ltd (standalone) |
| Revenue | 100 cr. | 2374 cr. | 29,164 cr. | 12480 cr. |
| PAT | -12.34 cr. | 551 cr. | 603 cr. | 229 cr. |
| EPS | -99 | 121 | 261.78 | 138 |
| EBITDA | -9.14 cr. | 824 cr. | 887 cr. | 343 cr. |
| Share price | 3299 | 6,130 | 7,132 | 5,201 |
| MCAP | 407.00 cr. | 28,031 cr. | 16,406 cr. | 8705 cr. |
| P/E Ratio | -33.32 | 183 | 33.4 | 40.46 |
| P/S Ratio | 4.08 | 12 | 1 | 0.7 |
| P/B Ratio | 2.38 | 20 | 24 | 16 |
| Book value per share | 1384 | 302 | 298 | 324 |
Key Achievements’ and Awards
SWOT Analysis
Anglo French Drug & Industries ltd unlisted shares are currently trading at ₹ 2999, CLICK HERE to Invest.
Read our other blogs
Get in touch with us
For any query/ personal assistance feel free to reach out at support@Altiusinvestech.com or call us at +91-8240614850.
To know, more about Unlisted Company. Click here – https://altiusinvestech.com/blog/what-is-listed-and-unlisted-company
To buy unlisted shares Visit – https://altiusinvestech.com/companymain
To know more about How to apply for an IPO? Click- https://altiusinvestech.com/blog/how-to-apply-for-an-ipo/
Visit our website homepage: https://altiusinvestech.com/